[Wolff-Parkinson-White syndrome and verapamil: apropos of a case of ventricular fibrillation].
Numerous highly effective antiarrhythmic agents are now available which have a powerful anti-arrhythmia action but may cause severe side effects in the case of inappropriate use. We report the case of a patient with WPW syndrome in whom inappropriate administration of verapamil during an episode of atrial fibrillation and rapid ventricular response caused ventricular fibrillation.
Michel
B
B
Département de médecine, Centre hospitalier universitaire vaudois, Lausanne.
Goy
J J
JJ
Kappenberger
L
L
D000328:Adult; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000209:etiology; D004562:Electrocardiography; D005260:Female; D006801:Humans; D014693:Ventricular Fibrillation / Q000139:chemically induced* / Q000175:diagnosis; D014700:Verapamil / Q000009:adverse effects* / Q000627:therapeutic use; D014927:Wolff-Parkinson-White Syndrome / Q000150:complications* / Q000188:drug therapy
D014700:Verapamil
Syndrome de Wolff-Parkinson-White et vérapamil: à propos d'un cas de fibrillation ventriculaire.